Navigation Links
Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
Date:1/27/2010

g proteins for therapeutic gene regulation and modification.  The most advanced ZFP Therapeutic™ development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS and another Phase 1 trial to evaluate safety and clinical effect of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developing sequence-specific ZFP Nucleases (ZFNs) for gene modification.  Sangamo has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's web site at http://www.sangamo.com/.

SOURCE Sangamo BioSciences, Inc.

RELATED LINKS
http://www.sangamo.com

'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)...  Corporate libraries are constantly being faced with a ... and how to cope with flat or shrinking budgets. ... medical device industries are increasingly finding it challenging to ... provide. According to recent research by ... of change that leading corporate libraries are being faced ...
(Date:7/25/2014)... Calif. , July 25, 2014  Depomed, Inc. ... will release second quarter fiscal year 2014 financial results ... Company will host a conference call beginning at 4:30 ... Participants can access the call by dialing 877-317-6789 ( ... conference call will also be available via a live ...
(Date:7/25/2014)... Calif. , July 25, 2014 /PRNewswire-iReach/ -- ... Nieto as the new Vice President of Business ... over 30 years in a number of different business ... the industry. These positions were primarily related to business ... over the past 30 years makes him a key ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... and other surgical and medical applications, has entered ... Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will ...
... 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On ... Programme (UNEP) distributed a revised text for ... mercury-free drugs were gratified to see pharmaceuticals listed in ... treaty. The Coalition for Mercury-free Drugs ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Chile 2Misonix Announces New Distribution Agreement for Chile 3Global Mercury Treaty May Include Ban on Mercury in Medicine 2Global Mercury Treaty May Include Ban on Mercury in Medicine 3
(Date:7/28/2014)... "We experienced difficulty filling our pill boxes ... inventors from Jamestown, Calif. "We came up with this ... could pour medications in more easily." , They created ... the lids open as the pill box is filled. ... have been filled. This eliminates hassles and frustrations, and ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
(Date:7/28/2014)... 2014 The research found that most ... food best, with each subsequent bite being less satisfying ... actually serve to sabotage the meal. , "People ... not realizing the effect," Baba Shiv, the study's author, ... moderation, if we needed one. You actually take more ...
(Date:7/28/2014)... 2014 Labors.at, Austria’s largest and ... Healthcare Relationship Cloud™ to fuel its growth initiatives. ... to 8,000 patients daily and performs up to ... up to doubling its volume within the next ... cutting-edge 10,000 square meter facility pushed our team ...
(Date:7/28/2014)... information about the measles, mumps and rubella (MMR) vaccine ... new University of Leeds research has found. , Informing ... helping parents make a decision about MMR is on ... informing them solely via a GP consultation, and 7.17 ... vaccine. In each case, the figure comprises the cost ...
Breaking Medicine News(10 mins):Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2Health News:Online information most cost-effective means of increasing MMR uptake, research finds 2
... (AMD) is the leading cause of severe visual loss ... common genetic variants which together predict a person,s increased ... without the disease also have these variants. Now, for ... show a specific rare mutation called CFH R1210C that ...
... Chapel Hill, NC In a study published today ... of scientists including UNC biologist Jason Lieb, PhD, present ... can survive with only one copy of the X ... topic in science and provides biologists with more information ...
... EAE President Doctor Luigi Badano, FESC, from the University ... we need to acquire information from all the different ... the ESC, the EAE,s philosophy is that we want ... oriented, so that we,re using the most appropriate technology ...
... Imagine having skin so supple you could stretch it out ... - repeatedly - yet it would always snap back completely ... never need Botox. That enviable elasticity is one of ... sensor that is the latest sensor developed by Stanford,s Zhenan ...
... 23 (HealthDay News) -- Gaining a significant amount of ... risk of developing endometrial cancer, a new study suggests. ... circulating estrogen in postmenopausal women, and estrogen promotes the ... of laboratory services at the National Home Office of ...
... Fla. October 24, 2011 A new analysis of recent eye ... to reduced rates of nearsightedness, also known as myopia, in ... the United States and many other countries than it was ... percent of the population is nearsighted. The analysis suggests that ...
Cached Medicine News:Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2Health News:Study confirms males and females have at least 1 thing in common: Upregulating X 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 3Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 2Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 3Health News:Weight Gain Might Raise Endometrial Cancer Risk 2Health News:More time outdoors may reduce kids' risk for nearsightedness 2
Shahinian lachrymal cannula, blunt tapered with side port....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Round serrated handle, polished finish, overall length 130 mm....
Medicine Products: